Pacific Biosciences of California Inc expected to post a loss of 28 cents a share - Earnings Preview

Pacific Biosciences of California

08/05/2024 01:01

* Pacific Biosciences of California Inc  PACB.OQ 
 PACB.O  is
expected to show a rise in quarterly revenue when it reports 
results on May 9 for the period ending March 31 2024
    * The Menlo Park California-based  company is expected to
report a
10.4% increase in revenue to $42.962 million from $38.9 million
a year ago, according to the mean estimate from 11 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Pacific Biosciences of
California Inc is for a loss of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Pacific
Biosciences of California Inc is $3.50​, above​ its last closing
price of $1.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.29       -0.29      -0.31     Missed  -8.7
 Sep. 30 2023  -0.34       -0.33      -0.26     Beat    20.8
 Jan. 1 0001   -0.32       -0.32      -0.28     Beat    12.7​
 Mar. 31 2023  -0.33       -0.33      -0.36     Missed  -8.3
 ​​Jan.        -0.37       -0.36      -0.37     Missed  -2.4
 1 0001                                                 
 Jan. 1 0001   -0.33       -0.33      -0.34     Missed  -2.5​
 Jun. 30 2022  -0.32       -0.32      -0.32     Met     1
 Mar. 31 2022  -0.31       -0.31      -0.37     Missed  -20
 This summary was machine generated May 8 at 00:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)